Category - Pharmaceutical Development

Showing 9 results 

Trial medicine: from production to participants

During clinical development the manufacturing and distribution facilities available may not be suitable for a trial medicine (investigational medicinal product (IMP)), however, IMPs must be manufactured, stored and distributed...

Read more »

Good Practice – GxP

GxP is an abbreviation for generic good practice, which refers to the series of laws, regulations, and guidance that govern various areas of the research, development, testing, manufacturing, and...

Read more »

Translational medicine

Translational medicine, a rapidly growing, multi-disciplinary approach in biomedical research, converts promising laboratory discoveries into clinical applications.

Read more »

Bioavailability and bioequivalence

Bioavailability is the fraction (percentage) of an administered dose of unchanged drug that reaches the blood stream (systemic circulation). Bioavailability varies between different pharmaceutical ingredients and mode of administration.

Read more »

Discovery and development of medicines

Once a target receptor molecule or an enzyme has been identified, scientists begin to look for potential compounds that will interact with the target to correct disease-related activity.These molecules...

Read more »

Search Toolbox

Find Out More